MCHP Stock Cash Flow Statements

Microchip Technology Quarterly Cash Flow Statements Chart

Quarterly

Annual

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Microchip Technology Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2017-12-31	2017-09-30	2017-06-30	2016-12-31	2016-09-30	2016-06-30	2015-12-31	2015-09-30	2015-06-30	2014-12-31	2014-09-30	2014-06-30	2013-12-31	2013-09-30	2013-06-30	2012-12-31	2012-09-30	2012-06-30	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31

cash flows from operating activities:
net income	-18,600,000	-154,600,000	-53,600,000	78,400,000	129,300,000	154,700,000	419,200,000	666,600,000	666,400,000	604,000,000	580,300,000	546,200,000	507,200,000	437,900,000	352,800,000	242,000,000	252,800,000	116,000,000	36,200,000	73,600,000	123,600,000	99,900,000	311,100,000	108,900,000	50,700,000	174,700,000	49,200,000	96,300,000	35,700,000	146,743,000	-251,086,000	189,156,000	170,587,000	107,175,000	33,919,000	-113,363,000	61,211,000	64,899,000	130,460,000	84,798,000	92,038,000	89,909,000	105,401,000	99,806,000	78,579,000	10,173,000	-21,184,000	78,710,000	77,489,000	79,287,000	99,293,000	125,528,000	100,776,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	171,100,000	187,000,000	186,800,000	187,600,000	188,700,000	218,200,000	219,400,000	219,000,000	222,900,000	243,200,000	244,000,000	251,800,000	259,400,000	293,200,000	300,600,000	277,500,000	272,200,000	287,800,000	286,900,000	285,800,000	292,800,000	310,900,000	300,000,000	297,600,000	307,100,000	238,700,000	243,900,000	221,000,000	172,800,000	156,868,000	154,676,000	152,555,000	151,801,000	114,968,000	112,816,000	113,141,000	76,178,000	71,109,000	60,375,000	73,303,000	70,821,000	60,988,000	45,242,000	48,052,000	50,410,000	64,012,000	51,211,000	25,245,000	24,642,000	25,177,000	25,351,000	26,459,000	27,177,000
deferred income taxes	-3,000,000	-17,500,000	-76,100,000	-41,600,000	-8,100,000	-71,300,000	17,100,000	3,100,000	23,900,000	20,100,000	54,100,000	56,600,000	74,700,000	1,800,000	17,300,000	-31,300,000	20,100,000	-56,000,000	-34,800,000	1,300,000	-49,400,000	-86,100,000	-293,300,000	-94,100,000	-16,800,000	-33,100,000	42,500,000	-158,800,000	87,200,000	-16,355,000	114,494,000	-25,061,000	-21,878,000	-34,395,000	-50,726,000	32,906,000	24,883,000	-18,490,000	-17,509,000	10,292,000	-2,178,000	-2,319,000	12,318,000	6,574,000	5,298,000	-556,000	-12,352,000	2,927,000	99,000	358,000	6,728,000	6,623,000	4,086,000
share-based compensation expense related to equity incentive plans	52,900,000	40,700,000	49,400,000	46,300,000	44,000,000	42,800,000	44,800,000	45,400,000	44,500,000	43,900,000	44,000,000	41,300,000	41,200,000	47,000,000	50,900,000	55,700,000	56,600,000	55,000,000	51,200,000	49,700,000	42,400,000	40,700,000	43,500,000	45,300,000	40,700,000	38,900,000	39,600,000	42,600,000	45,300,000	23,179,000	24,003,000	23,610,000	22,408,000	22,120,000	24,390,000	59,579,000	16,965,000	23,026,000	14,112,000	14,819,000	15,273,000	13,321,000	13,719,000	15,000,000	12,656,000	14,120,000	14,607,000	9,986,000	9,962,000	9,484,000	9,024,000	9,027,000	9,409,000
amortization of debt discount	1,400,000	13,200,000	23,500,000	11,500,000	16,600,000	18,700,000	14,000,000	3,100,000	1,700,000	1,800,000	1,800,000	1,800,000	1,800,000	10,000,000	10,700,000	11,600,000	12,600,000	13,600,000	14,400,000	17,800,000	25,300,000	30,800,000	30,700,000	30,300,000	29,900,000	29,400,000
amortization of debt issuance costs	1,400,000	1,700,000	1,800,000	2,300,000	2,000,000	1,600,000	1,700,000	1,800,000	2,200,000	2,400,000	2,400,000	2,400,000	2,300,000	2,300,000	2,800,000	2,900,000	3,500,000	3,900,000	4,200,000	4,200,000	4,800,000	4,300,000	4,300,000	4,300,000	4,200,000	4,400,000	3,700,000	5,400,000	3,000,000	1,648,000	1,613,000	1,718,000	1,621,000	1,064,000	1,061,000	1,057,000	996,000	962,000	958,000	544,000	544,000	544,000	544,000	545,000	327,000
impairment of intangible assets	2,200,000					500,000	200,000	600,000	500,000	400,000												1,700,000	0	0	500,000	0	0	1,100,000	2,000,000	248,000	37,000	87,000	128,000	8,242,000	0	1,984,000	47,000			1,305,000	150,000	406,000	0
other	-600,000	-17,500,000	-21,200,000	-5,900,000	-18,400,000	-14,400,000
changes in operating assets and liabilities, excluding impact of acquisitions:
increase in accounts receivable	-75,800,000						308,100,000	-241,200,000	-159,700,000	-130,300,000	-41,800,000	11,800,000	-72,400,000				-3,000,000								-56,200,000				-55,200,000	-10,538,000	-7,719,000			-18,119,000	-15,531,000	-9,901,000			-3,096,000		7,818,000	-37,247,000		1,769,000	-2,462,000		2,698,000	-2,814,000			-15,052,000		15,487,000
decrease in inventories	125,000,000																	900,000
increase in accounts payable and accrued liabilities	27,600,000			-141,100,000	-41,200,000	-124,400,000	-88,000,000	29,100,000	34,900,000	97,900,000	81,200,000	-8,100,000	152,400,000	118,900,000	70,500,000			11,000,000			-46,600,000				49,700,000		-105,700,000	-35,600,000	-2,200,000		15,976,000	-10,525,000	36,331,000			-18,000,000			16,157,000			-4,415,000			3,909,000			4,766,000		-32,513,000	-17,787,000	18,641,000	-22,607,000
change in other assets and liabilities	-3,400,000	34,600,000	-22,700,000	-29,300,000	-20,700,000	-107,600,000	-20,500,000	13,400,000	50,500,000	-3,500,000	418,600,000	32,200,000	-42,800,000	49,100,000	-8,800,000	11,600,000	27,500,000	6,600,000	-41,900,000	17,200,000	1,400,000	-9,200,000	-3,000,000	-15,300,000	14,400,000	-39,400,000	40,300,000	63,500,000	-88,600,000	-1,663,000	-1,058,000	24,017,000	-7,296,000	-625,000	-1,371,000	-12,270,000	-33,688,000	1,364,000	5,225,000	-18,486,000	-5,113,000	15,850,000	-10,392,000	5,214,000	14,977,000	-7,462,000	35,171,000	5,291,000	1,123,000	24,890,000	-10,873,000	-43,785,000	4,287,000
change in income tax payable	-4,600,000	-8,300,000	67,300,000	-88,600,000	27,800,000	60,200,000	-72,400,000	-133,300,000	107,000,000	-12,000,000	26,000,000	-17,600,000	-24,400,000	-10,100,000	45,800,000	-27,400,000	6,500,000	34,900,000	4,200,000	-38,400,000	16,700,000	18,000,000	-22,900,000	-11,500,000	-24,100,000	-27,300,000	-70,200,000	-79,400,000	-13,900,000	63,997,000
net cash from operating activities	275,600,000	205,900,000	271,500,000	43,600,000	377,100,000	430,000,000	853,300,000	616,200,000	993,200,000	709,500,000	1,277,900,000	793,200,000	840,400,000	747,700,000	853,400,000	611,700,000	629,900,000	449,200,000	509,700,000	455,800,000	501,800,000	371,700,000	395,500,000	396,000,000	380,600,000	403,400,000	481,500,000	487,500,000	302,400,000	359,518,000	364,959,000	350,131,000	344,992,000	290,802,000	222,123,000	223,967,000	210,477,000	149,886,000	181,528,000	184,838,000	192,046,000	165,788,000	153,868,000	154,924,000	164,431,000	128,907,000	63,300,000	128,971,000	55,939,000	154,754,000	83,305,000	152,537,000	138,677,000
cash flows from investing activities:
proceeds from capital-related government incentives	4,800,000	300,000	0	0	100,000	4,900,000
investments in other assets	-23,800,000	-42,100,000	-24,000,000	-45,800,000	-52,700,000	-36,000,000	-27,800,000	-19,500,000	-30,100,000	-38,600,000	-22,800,000	-20,500,000	-32,300,000	-30,000,000	-35,600,000	-29,700,000	-26,400,000	-15,900,000	-30,100,000	-35,400,000	-7,600,000	-31,000,000	-26,900,000	-11,000,000	-2,600,000	-5,800,000	-3,900,000	-7,300,000	-1,600,000	-1,716,000	-1,546,000	-1,905,000	-1,933,000	-6,365,000	-2,467,000	-765,000	-2,980,000	-1,215,000	-1,766,000	-1,615,000	-2,536,000	-1,123,000	-4,511,000	-1,335,000	-1,616,000	-1,814,000	-595,000	-1,609,000
capital expenditures	-17,900,000	-14,200,000	-18,100,000	-20,800,000	-72,900,000	-40,100,000	-59,500,000	-74,400,000	-111,100,000	-112,700,000	-141,300,000	-110,300,000	-121,900,000	-114,600,000	-90,700,000	-78,500,000	-86,300,000	-55,400,000	-21,400,000	-6,300,000	-9,500,000	-11,900,000	-14,100,000	-17,700,000	-23,900,000	-40,100,000	-27,400,000	-72,000,000	-89,400,000	-58,388,000	-66,387,000	-59,895,000	-22,130,000	-15,692,000	-18,152,000	-18,494,000	-17,869,000	-29,943,000	-33,611,000	-36,642,000	-38,735,000	-44,637,000	-24,330,000	-27,449,000	-27,757,000	-9,864,000	-15,908,000	-10,304,000	-6,133,000	-25,230,000	-27,219,000	-24,340,000	-34,177,000
free cash flows	257,700,000	191,700,000	253,400,000	22,800,000	304,200,000	389,900,000	793,800,000	541,800,000	882,100,000	596,800,000	1,136,600,000	682,900,000	718,500,000	633,100,000	762,700,000	533,200,000	543,600,000	393,800,000	488,300,000	449,500,000	492,300,000	359,800,000	381,400,000	378,300,000	356,700,000	363,300,000	454,100,000	415,500,000	213,000,000	301,130,000	298,572,000	290,236,000	322,862,000	275,110,000	203,971,000	205,473,000	192,608,000	119,943,000	147,917,000	148,196,000	153,311,000	121,151,000	129,538,000	127,475,000	136,674,000	119,043,000	47,392,000	118,667,000	49,806,000	129,524,000	56,086,000	128,197,000	104,500,000
net cash from investing activities	-36,900,000	-56,000,000	-42,100,000	-64,200,000	-125,500,000	-71,200,000	-86,200,000	-93,800,000	-140,900,000	-150,800,000	-164,100,000	-130,800,000	-153,800,000	-142,700,000	-126,300,000	-96,000,000	-112,700,000	-63,200,000	-51,500,000	-41,700,000	-16,900,000	-35,500,000	-43,000,000	-28,400,000	-26,300,000	-43,600,000	-31,400,000	-69,500,000	-6,666,500,000	-50,139,000	-369,588,000	-200,701,000	-391,272,000	-34,176,000	-20,591,000	-2,295,729,000	-53,908,000	-540,680,000	-187,189,000	-156,566,000	-247,763,000	-272,428,000	-64,837,000	-174,329,000	-209,193,000	-47,642,000	-951,055,000	77,890,000	-73,312,000	-72,214,000	-88,603,000	29,567,000	37,347,000
cash flows from financing activities:
proceeds from issuance of commercial paper		3,370,400,000	4,212,900,000	2,780,800,000	3,573,400,000	5,480,800,000	2,563,300,000
repayments of commercial paper	-174,100,000	-4,483,000,000	-4,460,300,000	-1,533,100,000	-4,637,500,000	-4,774,000,000
proceeds from issuance of convertible debt		0	0	0	1,250,000,000
deferred financing costs		-1,700,000	-1,500,000	-900,000	-15,600,000	-1,500,000	-500,000							-700,000	-5,200,000	-500,000	-2,100,000	-2,900,000	-11,500,000	-1,600,000	-5,200,000	-7,100,000	0			0	0	-100,000	-72,600,000	8,000	-394,000						-1,750,000	0	-406,000				0	0	-7,515,000
purchase of capped call options		-55,100,000	0	0	-105,000,000													0
proceeds from sale of common stock	12,400,000	20,000,000	11,800,000	20,500,000	13,100,000	24,400,000	17,100,000	25,300,000	15,300,000	28,000,000	16,500,000	24,400,000	13,400,000	23,400,000	13,700,000	21,200,000	12,200,000	20,100,000	10,600,000	18,600,000	11,000,000	20,000,000	11,300,000	20,200,000	7,300,000	15,700,000	6,600,000	13,800,000	6,500,000	15,424,000	7,008,000	15,094,000	4,474,000	3,441,000	20,822,000	4,630,000	4,396,000	10,023,000	3,497,000	6,794,000	9,910,000	4,125,000	2,556,000	15,296,000	6,900,000	6,301,000	11,357,000	4,961,000	14,743,000	7,395,000	18,272,000	20,593,000	29,078,000
tax payments related to shares withheld for vested rsus	-8,400,000	-12,600,000	-11,800,000	-14,300,000	-18,900,000	-14,200,000	-16,500,000	-14,700,000	-15,700,000	-18,600,000	-17,100,000	-20,700,000	-19,400,000	-17,300,000	-17,800,000
repurchase of common stock		0	-6,500,000	-17,300,000	-72,700,000	-387,400,000	-114,600,000	-339,800,000	-140,300,000	-273,900,000	-229,500,000	-247,200,000	-195,200,000	-259,600,000																							0
payment of cash dividends on series a preferred stock	-25,100,000
payment of cash dividends on common stock	-245,500,000
capital lease payments	-400,000	-400,000	-400,000	-400,000	-400,000	-400,000	-400,000	-400,000	-400,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	0	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-200,000	-213,000	-196,000	-196,000	-195,000	-196,000	-196,000	-195,000	-170,000	-168,000	-166,000	-152,000	-150,000	-148,000	-135,000	-134,000	-44,000
other financing	-2,800,000	-2,800,000
net cash from financing activities	-443,900,000	35,800,000	70,500,000	-8,400,000	-256,200,000	-320,100,000	-742,700,000	-537,000,000	-815,100,000	-613,600,000	-1,129,700,000	-734,700,000	-626,900,000	-601,100,000	-666,900,000	-540,100,000	-519,500,000	-476,700,000	-455,800,000	-424,000,000	-507,700,000	-332,300,000	-357,200,000	-399,800,000	-348,900,000	-363,400,000	-477,600,000	-593,500,000	6,098,000,000	-80,174,000	-149,699,000	-96,059,000	-89,368,000	-82,043,000	-312,174,000	580,015,000	-364,196,000	366,325,000	-38,607,000	-53,372,000	-80,413,000	257,807,000	-58,133,000	-39,624,000	-80,341,000	-52,354,000	543,303,000	-62,768,000	-52,031,000	-58,794,000	-47,243,000	21,204,000	-99,129,000
net decrease in cash and cash equivalents	-205,200,000															-24,400,000	-2,300,000	-90,700,000	2,400,000			3,900,000	-4,700,000								-154,328,000	53,371,000	-135,648,000	173,950,000	-110,538,000	-1,492,225,000							30,898,000			28,558,000
cash and cash equivalents, at beginning of period	771,700,000	0
cash and cash equivalents, at end of period	566,500,000	185,700,000
loss on settlement of debt		1,400,000				0	0	3,100,000	9,100,000	0	0	2,100,000	6,200,000	11,800,000	16,100,000	85,200,000	300,000	85,600,000	142,100,000	45,100,000	26,800,000	3,400,000	0	100,000	1,900,000	8,300,000	200,000
decrease (increase) in accounts receivable		167,500,000	187,100,000	51,500,000	47,900,000																39,700,000					49,400,000	124,000,000																						-6,868,000
decrease (increase) in inventories					9,200,000	-3,400,000														-3,500,000	24,900,000					-2,900,000	83,000,000	177,700,000	83,800,000						94,848,000	121,102,000				-3,368,000	7,061,000	24,991,000				24,812,000	22,018,000	316,000
other investing		0	0
proceeds from borrowings on revolving credit facility						720,000,000	0	2,966,000,000	2,585,000,000	1,914,000,000	1,256,000,000	1,459,000,000	1,306,000,000	1,229,000,000	1,002,000,000
repayments of revolving credit facility						-720,000,000	-39,000,000	-3,652,000,000	-1,960,000,000	-2,067,000,000	-1,975,100,000	-1,687,000,000	-1,505,000,000	-1,370,000,000	-1,268,500,000
proceeds from borrowings on 2025 term loan facility						0	0
repayments of 2025 term loan facility		0
proceeds from issuance of senior notes		0												0	0	0	997,000,000	0	1,395,800,000	0	2,182,000,000
repayment of senior notes		0	0			-1,400,000,000	0	-1,000,000,000	-1,000,000,000					0	0	0	-1,000,000,000
payments on settlement of convertible debt		-3,700,000				0	0	-42,700,000	-90,100,000	0	0	-96,900,000	-73,500,000	-64,900,000	-96,200,000			-359,200,000	-428,900,000	-796,100,000	-1,027,200,000									21,000
issuance of series a preferred stock
payment of cash dividends		-244,800,000	-244,600,000	-243,700,000	-242,600,000	-242,500,000	-237,400,000	-222,700,000	-208,900,000	-195,900,000	-180,300,000	-166,100,000	-153,000,000	-140,800,000	-128,700,000	-121,200,000	-113,100,000	-106,600,000	-96,000,000	-95,300,000	-90,400,000	-88,000,000	-87,700,000	-87,300,000	-87,100,000	-86,600,000	-86,400,000	-85,900,000	-85,500,000	-85,140,000	-84,912,000	-84,520,000	-82,928,000	-77,970,000	-77,640,000	-77,237,000	-72,923,000	-72,685,000	-72,331,000	-71,787,000	-71,442,000	-71,202,000	-70,554,000
net increase in cash and cash equivalents		185,700,000	299,900,000	-29,000,000	-4,600,000	38,700,000	24,400,000	-14,600,000	37,200,000	-54,900,000			59,700,000	3,900,000							-22,800,000				5,400,000													-24,469,000	-44,268,000		-136,331,000	151,167,000			-125,103,000			144,093,000			-52,541,000	203,308,000	76,895,000
increase in inventories			-16,800,000					5,500,000	-10,600,000	-158,400,000	-134,600,000	-125,200,000	-65,000,000	-72,800,000	-55,200,000	-30,600,000	-19,200,000							300,000	-20,500,000					10,983,000	-30,034,000	-30,245,000	-9,904,000					19,296,000	-23,893,000				1,515,000	-18,146,000	-13,957,000				-6,223,000	-8,690,000	-21,384,000	-1,289,000	-10,744,000
decrease in accounts payable and accrued liabilities																	-900,000						-44,900,000											-244,000			-12,991,000			-23,184,000			-19,864,000			-30,869,000
cash and cash equivalents, and restricted cash at beginning of period				0	319,700,000	0	0	0	234,000,000	0	0	0	317,400,000	0	0	0	280,000,000	0	0	0	401,000,000	0	0	0	428,600,000	0	0	0	901,300,000
cash and cash equivalents, and restricted cash at end of period				-29,000,000	315,100,000	38,700,000	24,400,000	-14,600,000	271,200,000	-54,900,000	-15,900,000	-72,300,000	377,100,000	3,900,000	60,200,000	-24,400,000	277,700,000	-90,700,000	2,400,000	-9,900,000	378,200,000	3,900,000	-4,700,000			-3,600,000	-27,500,000	-175,500,000	635,200,000
proceeds from sales of assets						0	0	100,000	300,000	500,000	0	0	400,000	1,900,000	0
supplemental disclosure of cash flow information:
non-cash activities:
rou assets obtained in exchange of lease liabilities
other non-cash adjustment								0	-100,000	0	500,000	-2,100,000	-200,000	-1,900,000	-5,600,000	-4,800,000	900,000		0	400,000	500,000				-100,000
repayment of bridge loan facility																		0	0	0	-615,000,000
repayments of term loan facility																		0	-1,705,700,000	0	-17,800,000	0	0	0	-188,000,000	-801,500,000	-20,000,000
cash paid for:
purchases of available-for-sale investments																						0				0	0	0	-167,700,000	-256,660,000	-458,703,000	-392,002,000	-487,435,000	-35,122,000	0	-25,000	-430,775,000	-541,588,000	-570,501,000	-371,263,000	-178,092,000	-172,506,000	-240,363,000	-333,737,000	-376,460,000	-203,318,000	-413,976,000	-29,130,000	-296,404,000	-340,822,000	-324,893,000	-148,749,000	-62,430,000
sales of available-for-sale investments and marketable equity securities
proceeds from borrowings on bridge loan facility
decrease in accounts receivable															55,500,000				9,900,000				41,100,000
proceeds from sale of assets																		8,100,000	0	0	200,000	2,700,000	0	300,000	200,000	0	100,000	0	100,000	11,000	48,000	15,000	10,226,000	23,003,000	14,000	52,000	0	13,669,000	627,000				0	0	16,200,000	240,000	16,000	50,000	164,000			1,109,000	2,129,000
proceeds from borrowings on revolving loan under credit facility																	775,000,000	893,000,000	869,000,000	966,000,000	1,238,000,000	344,000,000	255,000,000	223,000,000	204,000,000	691,000,000	93,000,000	147,000,000	3,485,500,000	0	74,000,000	53,000,000	60,000,000	132,000,000	105,000,000	1,280,000,000	93,000,000	879,500,000	145,000,000
repayments of revolving loan under credit facility																	-1,163,000,000	-903,000,000	-432,000,000	-501,000,000	-2,171,900,000	-580,000,000	-512,000,000	-538,500,000	-273,500,000	-167,000,000	-450,500,000	-381,000,000	-151,500,000	0	-74,000,000	-53,000,000	-60,000,000	-127,000,000	-349,500,000	-602,000,000	-381,000,000	-80,000,000	-110,000,000
tax payments related to shares withheld for vested restricted stock units																	-25,300,000	-18,100,000	-21,100,000	-14,400,000	-11,000,000	-17,900,000	-23,600,000	-15,200,000	-11,400,000	-14,800,000	-20,100,000	-20,100,000	-16,800,000	-10,274,000	-12,950,000	-10,457,000	-10,719,000	-12,318,000	-10,660,000	-25,183,000	-6,077,000	-6,660,000	-4,464,000	-3,970,000	-5,338,000	-4,968,000
losses on equity method investments																										0	100,000	0	100,000	33,000	56,000	56,000	55,000	55,000	56,000	56,000	56,000	56,000	177,000	62,000	35,000	32,000	-150,000	101,000	260,000	229,000	32,000	121,000		13,000	61,000
gains on sale of assets																				0	-900,000									-479,000	-40,000	-816,000	-4,565,000	-3,000	-14,000	-61,000
losses on write-down of fixed assets																						0				300,000					7,000	5,000	48,000	961,000
gains on equity investments																		0
impairment of available-for-sale investments
amortization of premium on available-for-sale investments																										0	0	0	-200,000	-231,000	-62,000	117,000	476,000			13,000	2,498,000	2,336,000	2,396,000	2,495,000	2,477,000	2,589,000
maturities of available-for-sale investments																										2,300,000	-200,000	9,200,000	66,700,000	266,614,000	157,000,000
acquisition of microsemi, net of cash acquired																										0	0	600,000	-7,851,200,000
proceeds from borrowings on term loan facility																										0	0	0	3,000,000,000
repayment of debt assumed in microsemi acquisition																										0	0	0	-2,056,900,000
restricted cash
interest
income taxes
operating lease payments in operating cash flows
during the fiscal year ended march 31, 2021, the company completed the december 2020 settlement of 1,086.5 million principal amount of convertible debt in exchange for 428.9 million in cash, 8.4 million shares of common stock and 665.5 million principal amount of 2020 senior convertible debt. refer to note 7 for further information.
during the fiscal year ended march 31, 2020, the company adopted accounting standards codification topic 842, leases, using the retrospective cumulative effect adjustment transition method. the disclosures are not applicable for the fiscal year ended march 31, 2019.
(gains) losses on sale of assets
during the nine months ended december 31, 2020, the company completed the december 2020 settlement of 1,086.5 million principal amount of convertible debt in exchange for 428.9 million in cash, 8.4 million shares of common stock and 665.5 million principal amount of 2020 senior convertible debt. refer to note 6 for further information.
gains on available-for-sale investments and marketable equity securities																				0	-200,000
supplemental disclosure of cash flow information
gains on marketable equity securities
increase in deferred income on shipments to distributors																														-1,890,000	11,342,000	15,566,000	15,982,000	71,063,000	10,025,000	29,739,000	-16,380,000	12,091,000	1,401,000	-5,321,000	13,002,000	-1,215,000	-7,734,000	1,232,000	10,865,000	-511,000	953,000	2,084,000	-28,399,000	-1,413,000	5,554,000	-2,641,000	10,403,000
proceeds from issuance of 2023 and 2021 senior notes																										0	0	0	1,989,500,000
right-of-use assets obtained in exchange of lease liabilities
losses on sale of assets
(gains) losses on available-for-sale investments and marketable equity securities																							0	-200,000	-800,000
sales of available-for-sale investments																										0	0	0	1,376,600,000
losses on available-for-sale investments and marketable equity securities
realized gain on equity method investment																																					0	0	-2,225,000
impairment of available-for-sale investment
operating cash flows related to discontinued operations																																		-966,000	4,318,000	5,996,000
sale of equity method investment																																		0	0	468,000	0	0	2,667,000
acquisition of atmel, net of cash acquired																																		0	0	-2,747,516,000
proceeds from issuance of 2017 senior convertible debt
proceeds from issuance of 2017 junior convertible debt
effect of foreign exchange rate changes on cash and cash equivalents																																		-633,000	104,000	-478,000				0						-353,000
net decrease in cash, cash equivalents, and restricted cash																											-27,500,000	-175,500,000	-266,100,000
amortization of debt discount on convertible debt																												27,900,000	27,500,000	27,083,000	26,711,000	26,353,000	25,953,000
losses on available-for-sale investments																												1,000,000	5,200,000
loss on settlement of convertible debt																														34,000	2,140,000	0	13,826,000
other non-cash adjustments																													-100,000
excess tax benefit from share-based compensation																																					-328,000	-144,000	-263,000	-118,000						-42,000	-92,000	-20,000	-39,000	-17,000	-385,000	-614,000
loss on write-down of fixed assets																																				269,000
realized losses (gain) on available-for-sale investments
acquisition of micrel, net of cash acquired																																					0
purchase of additional controlling interest in issc																																					0	0	-18,051,000	-21,169,000
proceeds from issuance of 2017 senior debt
proceeds from issuance of 2017 junior debt
cash and cash equivalents at beginning of period																														16,000	0	0	908,684,000	0	0	2,092,751,000	0	0	607,815,000	0	0	466,603,000	0	0	528,334,000	0	0	635,755,000	0	0	703,924,000		0
cash and cash equivalents at end of period																														229,221,000	-154,328,000	53,371,000	773,036,000	173,950,000	-110,538,000	600,526,000	-207,627,000	-24,469,000	563,547,000	-25,100,000	-136,331,000	617,770,000	30,898,000	-59,029,000	403,231,000	28,558,000	-343,113,000	779,848,000	-69,404,000	23,746,000	651,383,000		76,895,000
realized losses on available-for-sale investment
realized gains on equity method investment																																		0	0	-468,000
payments on conversion of convertible debt
(increase) in accounts receivable																																	-50,581,000
sales and maturities of available-for-sale investments																																	110,000,000	0	14,000	470,551,000	397,716,000	362,325,000	433,446,000	274,123,000	225,834,000	321,203,000	213,380,000	188,192,000	182,614,000	167,114,000	211,154,000	139,439,000	230,793,000	297,960,000	264,485,000	216,291,000	145,235,000
amortization of debt discount on convertible debentures																																		12,494,000	12,307,000	12,106,000	12,163,000	11,974,000	11,772,000	2,501,000	2,445,000	2,365,000	2,286,000	2,235,000	2,161,000	2,089,000	2,042,000	1,975,000	1,909,000	1,866,000	1,805,000	1,746,000	1,745,000
realized losses (gains) on available-for-sale investment																																		0	7,000	82,000
special charges (income) and other
special charges																																					840,000
gain on sale of assets																																					-100,000	-300,000	-560,000							-240,000			-164,000			0	-50,000
realized gain on available-for-sale investment																																					-95,000	0	-13,959,000
changes in operating assets and liabilities:
acquisition of issc, net of cash acquired																																								0
acquisition of supertex, net of cash acquired																																								0	0	-375,365,000
repayments of long-term borrowings																																								-4,375,000	-4,375,000	-4,375,000
convertible debt derivatives - revaluation and amortization																																								33,000	57,000	-11,000	-201,000	-264,000	16,000	-336,000	259,000	330,000	61,000	396,000	-30,000		-249,000
special income																																											-762,000
gain on shares of acquired company
other business acquisitions, net of cash acquired																																											-9,013,000			0
repayments of revolving loan under previous credit facility																																											0	0	-650,000,000
repayments of revolving loan under new credit facility																																								-119,400,000	-138,500,000	-170,000,000	-83,500,000
proceeds from borrowings on revolving loan under previous credit facility																																											0	0	30,000,000
proceeds from borrowings on revolving loan under new credit facility																																								139,400,000	128,500,000	504,375,000	93,500,000	100,000,000	260,000,000
proceeds from issuance of long-term borrowings																																											0	0	350,000,000
contingent consideration payment																																											0
special charge																																													1,392,000
unrealized impairment loss on available-for-sale investments																																														78,000			204,000	2,064,000	945,000	3,396,000	422,000
acquisition of smsc, net of cash acquired																																														0
business acquisitions, net of cash acquired																																													-2,174,000
payment of cash dividend																																													-69,682,000	-68,697,000	-68,146,000	-67,749,000	-66,813,000	-66,206,000	-65,900,000	-3,000	-129,447,000
amortization of convertible debenture issuance costs																																														55,000	55,000	54,000	55,000	55,000	55,000		55,000
proceeds from borrowings on line of credit																																														10,000,000
business acquisitions																																																-20,556,000
losses (gains) on equity method investments
purchase of silicon storage technology, inc., net of cash received																																																					0
investment in other assets																																																		-4,170,000	-976,000	-14,744,000	-13,410,000
adjustments to reconcile net income to net cash from operating
activities:
convertible debt derivatives – revaluation and amortization
amortization of junior convertible debenture issuance costs
gains on equity method investments																																																				28,000
sales (purchases) of trading securities
(gain) loss on trading securities
purchase of silicon storage technology, net of cash received
investment in silicon storage technology
cash and cash equivalents at beginning of year
cash and cash equivalents at end of year
see accompanying notes to consolidated financial statements
sales of trading securities
gain on trading securities
see accompanying notes to condensed consolidated financial statements

We provide you with 20 years of cash flow statements for Microchip Technology stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Microchip Technology stock. Explore the full financial landscape of Microchip Technology stock with our expertly curated income statements.

The information provided in this report about Microchip Technology stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.